INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,566,268 | -17.7% | 260,439 | 0.0% | 1.22% | -15.3% |
| Q2 2023 | $16,490,997 | +16.9% | 260,439 | 0.0% | 1.44% | +7.6% |
| Q1 2023 | $14,102,772 | -6.0% | 260,439 | -8.1% | 1.33% | -9.1% |
| Q4 2022 | $14,999,592 | +13.7% | 283,439 | 0.0% | 1.47% | +7.0% |
| Q3 2022 | $13,188,000 | -18.5% | 283,439 | 0.0% | 1.37% | -15.6% |
| Q2 2022 | $16,179,000 | -6.7% | 283,439 | 0.0% | 1.62% | +14.8% |
| Q1 2022 | $17,344,000 | +16.9% | 283,439 | 0.0% | 1.42% | +21.8% |
| Q4 2021 | $14,835,000 | +13.4% | 283,439 | -19.2% | 1.16% | +4.9% |
| Q3 2021 | $13,078,000 | -8.7% | 350,804 | 0.0% | 1.11% | -7.5% |
| Q2 2021 | $14,320,000 | +21.4% | 350,804 | +1.0% | 1.20% | +8.9% |
| Q1 2021 | $11,791,000 | +6.7% | 347,497 | 0.0% | 1.10% | +0.7% |
| Q4 2020 | $11,050,000 | +23.9% | 347,497 | 0.0% | 1.09% | +6.2% |
| Q3 2020 | $8,917,000 | +30.3% | 347,497 | +30.4% | 1.03% | +18.5% |
| Q2 2020 | $6,842,000 | +67.0% | 266,527 | 0.0% | 0.87% | +56.4% |
| Q1 2020 | $4,097,000 | -64.0% | 266,527 | -19.6% | 0.56% | -46.7% |
| Q4 2019 | $11,375,000 | +345.9% | 331,527 | -2.9% | 1.04% | +313.5% |
| Q3 2019 | $2,551,000 | -34.5% | 341,527 | +13.9% | 0.25% | -31.7% |
| Q2 2019 | $3,893,000 | +6.6% | 299,942 | 0.0% | 0.37% | +1.9% |
| Q1 2019 | $3,653,000 | +6.9% | 299,942 | 0.0% | 0.36% | +0.8% |
| Q4 2018 | $3,416,000 | – | 299,942 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |